Green Cross Becomes First Korean Pharma To Export Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's vaccine producer Green Cross shipped its first batch of flu vaccine GCFlu to the World Health Organization's Pan American Health Organization June 8 in accordance with a $6 million deal signed in March.Noting that it is the first Korean pharma to export seasonal flu vaccine, Green Cross said it is to make the second and third shipments of the vaccine by the end of June
You may also be interested in...
Korea's Green Cross Strengthens Vaccine Supply Chain For Growing Export Demand
SEOUL - South Korea's leading vaccine producer Green Cross has opened and begun operation of a vaccine egg farm to build up a stable channel for the supply of flu vaccine eggs to the pharma's vaccine plant in Hwasoon, Southwest of Seoul. The company is preparing for increased domestic competition, but it also benefiting from a pickup in foreign demand
Korea's Green Cross Strengthens Vaccine Supply Chain For Growing Export Demand
SEOUL - South Korea's leading vaccine producer Green Cross has opened and begun operation of a vaccine egg farm to build up a stable channel for the supply of flu vaccine eggs to the pharma's vaccine plant in Hwasoon, Southwest of Seoul. The company is preparing for increased domestic competition, but it also benefiting from a pickup in foreign demand
Korean Pharmas Rush Into Vaccines: SK Chemicals Breaks Ground For Cell-culture Vaccines With Aid From Xcellerex
SEOUL - South Korea's SK Chemicals joined the race with domestic manufacturers for cell-culture vaccine production, breaking ground June 15 for a cell-culture vaccine plant that will produce vaccines via a biomanufacturing platform from U.S.-based vaccine maker Xcellerex starting in the second half of 2014